Elections

Latest California Healthline Stories

KHN’s ‘What the Health?’: Graham’s Bill Recenters Abortion Debate

Republicans would like to shift the political focus away from abortion to economic issues for the midterm elections, but a bill from Sen. Lindsey Graham (R-S.C.) that would ban most abortions after 15 weeks of pregnancy has put the issue squarely back on their agenda. The proposal was not welcomed by many of his colleagues, especially Minority Leader Mitch McConnell. Also this week, the muddle about where the fight against covid stands and near-record-low numbers of uninsured in the U.S. Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Margot Sanger-Katz of The New York Times join KHN’s partnerships editor, Mary Agnes Carey, to discuss these issues and more.

KHN’s ‘What the Health?’: Kansas Makes a Statement

In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.

California’s Public Health Tax Is Dead for the Year

A ballot measure that would have taxed California millionaires to boost public health funding will not be on the November ballot. But the tech titans who bankrolled the effort say they are negotiating with Gov. Gavin Newsom’s administration to get more money without imposing new taxes.

KHN’s ‘What the Health?’: FDA Takes Center Stage

Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.